Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Payables (2016 - 2025)

iBio (IBIO) has disclosed Payables for 15 consecutive years, with $2.7 million as the latest value for Q4 2025.

  • Quarterly Payables rose 118.44% to $2.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Dec 2025, up 118.44% year-over-year, with the annual reading at $3.0 million for FY2025, 412.85% up from the prior year.
  • Payables for Q4 2025 was $2.7 million at iBio, down from $3.5 million in the prior quarter.
  • The five-year high for Payables was $27.0 million in Q3 2022, with the low at $576000.0 in Q2 2024.
  • Average Payables over 5 years is $8.8 million, with a median of $3.2 million recorded in 2025.
  • The sharpest move saw Payables soared 1078.36% in 2022, then tumbled 96.1% in 2024.
  • Over 5 years, Payables stood at $2.7 million in 2021, then skyrocketed by 630.67% to $20.0 million in 2022, then fell by 27.48% to $14.5 million in 2023, then plummeted by 91.63% to $1.2 million in 2024, then surged by 118.44% to $2.7 million in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $2.7 million, $3.5 million, and $3.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.